HORIBA launches new compact hematology analyzers with combined ESR and CBC/DIFF

June 24, 2024
Yumizen H550 range expands to affordably introduce new applications and configurable hematology options for small to mid-throughput laboratories.

HORIBA expanded its compact hematology instrument range with the launch of new models with Erythrocyte Sedimentation Rate (ESR) on board.

The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) now offer combined testing for CBC/DIFF with ESR results from whole blood in 60 seconds.

HORIBA has developed the innovative “CoRA” (Correlated Rouleaux Analysis) technology to integrate ESR into its three new analyzers. Combining complete blood count (CBC) and 5-population white blood cell differential (DIFF) with rapid ESR, calibrated to the Westergren reference method, on one compact analyzer reduces costs per test and turnaround times, and saves laboratory space. This CoRA technology is patented by HORIBA.

Other key advancements have included i-DoubleDiff technologies to enhance speed of diagnoses:

- “I” for Infectious screening: by using artificial intelligence, the analyzer can display score flags for infectious diseases such as Malaria and Dengue Fever.

- “DoubleDiff”: Normal leucocyte count (Lymphocyte, Monocyte, Neutrophil, Eosinophil, Basophil) + Abnormal leucocyte count (IMG, IMM, IML, LIC, ALY). Requiring just two reagents, this increased analytical capability from 27 to 37 parameters.

HORIBA release